VANCOUVER, BC / ACCESS Newswire / January 26, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
MS is an autoimmune disorder in which the immune system attacks myelin, the protective covering of nerve fibres in the brain ...
The drug, tolebrutinib, delayed disability progression by 31% in people with a type of MS called non-relapsing secondary progressive multiple sclerosis, researchers reported in the New England Journal ...
Researchers from Kyushu University have identified a potential therapeutic target for the treatment of advanced multiple sclerosis (MS), a potentially disabling condition associated with the central ...
Experts unite to strengthen awareness and advanced care for multiple sclerosis: Our Bureau, Bengaluru Tuesday, January 20, 2026, 16:50 Hrs [IST] Multiple Sclerosis Society of Indi ...
AUGS Overactive Bladder Symptoms in Patients With Multiple Sclerosis Patients with multiple sclerosis have significant rates of overactive bladder symptoms, yet they are not being evaluated or treated ...
Differences in the complexity of the EEG signal (yellow and red colors) in a specific brain area between the group with advanced multiple sclerosis and the control group, and multifractal spectra ...
Journals Flag Concerns in 36 Papers by Nutrition Researchers Journals have flagged more than 36 articles by a team of authors in Iran for concern over the integrity of their data since questions were ...
While recent therapies have the potential to stall or delay the progression of multiple sclerosis, a new study shows that young Black and Hispanic women fare worse than young white women. Minority ...
An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed ...
Bengaluru Chapter, in collaboration with the Rotary Action Group Against Multiple Sclerosis (RAGAMS), hosted an awareness and ...